Ispecimen Inc. (ISPC) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ispecimen Inc. (ISPC:NASDAQ), powered by AI.

Current Price
$0.13
P/E Ratio
-0.0
Market Cap
94,685
Sector
Healthcare
What is the Ispecimen Inc. stock price forecast?

Ispecimen Inc. is currently trading at $0.13. View real-time AI analysis on Alpha Lenz.

What is Ispecimen Inc. insider trading activity?

View the latest insider trading data for Ispecimen Inc. on Alpha Lenz.

What is Ispecimen Inc.'s P/E ratio?

Ispecimen Inc.'s P/E ratio is -0.0.

Ispecimen Inc.

NASDAQ · ISPC
$0.13
Ask about Ispecimen Inc.'s future dividend policy...
Alpha Chat Insight

Ispecimen Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -191.5%.

Ask for details

Company Overview

Ispecimen Inc. is a technology-driven biospecimen marketplace company focused on transforming the way healthcare researchers procure biological samples for advancing medical science. By utilizing its proprietary iSpecimen Marketplace platform, the company enables researchers to connect with a vast network of healthcare providers, leveraging existing clinical data to efficiently match sample requests. This process enhances the accessibility and streamlines the acquisition of human material, such as tissues, blood, and other biological samples, crucial for medical research and diagnostics development. Operating predominantly within the life sciences sector, Ispecimen Inc. plays a significant role in facilitating advancements in personalized medicine, diagnostics, and therapeutic development. Founded in 2009 and headquartered in Lexington, Massachusetts, the company not only supports research institutions but also contributes to the optimization of clinical specimen supply chains, thereby accelerating scientific discovery and innovation in the healthcare industry.

CEOMr. Robert Bradley Lim
SectorHealthcare
IndustryDiagnostics & Research
Employees24

Company Statistics

FY 2024

Profile

$94.69KMarket Cap
$9.29MRevenue
0.00Shares Out
24Employees

Margins

42.93%Gross
-107.45%EBITDA
-136.99%Operating
-134.51%Pre-Tax
-134.51%Net

Valuation

-0.01P/E
0.03P/B
0.01EV/Sales
0.15EV/EBITDA
-0.01P/FCF

Growth (CAGR)

-5.86%Rev 3Yr
16.67%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-99.31%ROA
-191.51%ROE
-97.56%ROIC

Financial Health

$1.88MCash & Cash Equivalents
$4.16MNet Debt
182.40%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Ispecimen Inc. (ticker: ISPC) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 24 employees. Market cap is $94,685.

The current price is $0.133 with a P/E ratio of -0.01x and P/B of 0.03x.

ROE is -191.51% and operating margin is -136.99%. Annual revenue is $9M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Ispecimen Inc. (Healthcare) Stock Forecast & Analysis $0.13 | Alpha Lenz